|Last Price||Today's Change||52-Week Range||Trading Volume|
|29.38||-0.11 (-0.37%)||27.81 - 32.96||20.6 million|
Market data as of 4:01PM 08/28/14. Quotes are delayed by at least 15 min.
Pfizer and Protalix BioTherapeutics Announce FDA Approval of Pediatric Indication for ELELYSO™ (taliglucerase alfa) for Injection, for Intravenous Use for the Treatment of Type 1 Gaucher Disease
08/28/2014 1:15 PM ET